DK0611767T3 - Heterocyclisk substituerede phenylcyclohexancarboxylsyrederivater som angiotension II-antagonister - Google Patents

Heterocyclisk substituerede phenylcyclohexancarboxylsyrederivater som angiotension II-antagonister

Info

Publication number
DK0611767T3
DK0611767T3 DK94101543T DK94101543T DK0611767T3 DK 0611767 T3 DK0611767 T3 DK 0611767T3 DK 94101543 T DK94101543 T DK 94101543T DK 94101543 T DK94101543 T DK 94101543T DK 0611767 T3 DK0611767 T3 DK 0611767T3
Authority
DK
Denmark
Prior art keywords
angiotension
antagonists
carboxylic acid
acid derivatives
heterocyclic substituted
Prior art date
Application number
DK94101543T
Other languages
Danish (da)
English (en)
Inventor
Siegfried Dr Zaiss
Stefan Dr Wohlfeil
Andreas Dr Knorr
Juergen Dr Dressel
Peter Dr Fey
Walter Dr Huebsch
Thomas Dr Kraemer
Ulrich E Dr Mueller
Stanislav Prof Dr Kazda
Johannes-Peter Dr Stasch
Matthias Dr Mueller-Gliemann
Rudolf H Dr Hanko
Martin Dr Beuck
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0611767T3 publication Critical patent/DK0611767T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK94101543T 1993-02-15 1994-02-02 Heterocyclisk substituerede phenylcyclohexancarboxylsyrederivater som angiotension II-antagonister DK0611767T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4304455A DE4304455A1 (de) 1993-02-15 1993-02-15 Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate

Publications (1)

Publication Number Publication Date
DK0611767T3 true DK0611767T3 (da) 2001-01-02

Family

ID=6480447

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94101543T DK0611767T3 (da) 1993-02-15 1994-02-02 Heterocyclisk substituerede phenylcyclohexancarboxylsyrederivater som angiotension II-antagonister

Country Status (25)

Country Link
US (1) US5395840A (cs)
EP (1) EP0611767B1 (cs)
JP (1) JPH06293741A (cs)
KR (1) KR940019708A (cs)
CN (1) CN1057085C (cs)
AT (1) ATE196141T1 (cs)
AU (1) AU672262B2 (cs)
CA (1) CA2115536C (cs)
CZ (1) CZ289096B6 (cs)
DE (2) DE4304455A1 (cs)
DK (1) DK0611767T3 (cs)
ES (1) ES2151908T3 (cs)
FI (1) FI106716B (cs)
GR (1) GR3034957T3 (cs)
IL (1) IL108625A (cs)
MY (1) MY131595A (cs)
NO (1) NO300810B1 (cs)
NZ (1) NZ250864A (cs)
PH (1) PH30172A (cs)
PL (1) PL177834B1 (cs)
PT (1) PT611767E (cs)
RU (1) RU2119480C1 (cs)
SK (1) SK15294A3 (cs)
UA (1) UA35574C2 (cs)
ZA (1) ZA94984B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW300219B (cs) * 1991-09-14 1997-03-11 Hoechst Ag
DE19503160A1 (de) * 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden
HRP960015B1 (en) * 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
EP0994877A1 (en) * 1997-07-03 2000-04-26 Du Pont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
ATE302758T1 (de) * 1998-11-17 2005-09-15 Abbott Gmbh & Co Kg 2-phenylbenzimidazole und 2-phenylindole, deren herstellung und anwendung
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE10044792A1 (de) * 2000-09-11 2002-04-04 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung
ES2443616T3 (es) 2006-05-09 2014-02-19 Mitsubishi Gas Chemical Company, Inc. Procedimiento para la isomerización de alquilciclohexilbenceno
PL2442809T3 (pl) 2009-06-17 2017-02-28 Vertex Pharmaceuticals Incorporated Inhibitory replikacji wirusów grypy
CN103492381A (zh) 2010-12-16 2014-01-01 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
CA2839703A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
CA2839699A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
AP3902A (en) 2012-06-29 2016-11-17 Pfizer Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
HUE038820T2 (hu) 2013-11-13 2018-11-28 Vertex Pharma Eljárás influenzavírusok replikációjának inhibitorai elõállítására
DK3068776T3 (da) 2013-11-13 2019-07-29 Vertex Pharma Inhibitorer af replikation af influenzavira
EP3083618B1 (en) 2013-12-17 2018-02-21 Pfizer Inc Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2017046675A1 (en) 2015-09-14 2017-03-23 Pfizer Inc. Novel imidazo [4,5-c] quinoline and imidazo [4,5-c][1,5] naphthyridine derivatives as lrrk2 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
DK0461039T3 (da) * 1990-06-08 1999-06-14 Hoechst Marion Roussel Inc Nye benzimidazolafledte forbindelser, fremgangsmåde til deres fremstilling, de opnåede mellemprodukter, deres anvendelse so
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
EP0470543A1 (de) * 1990-08-10 1992-02-12 Dr. Karl Thomae GmbH Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
DE4031635A1 (de) * 1990-10-05 1992-04-09 Thomae Gmbh Dr K Substituierte 1-benzyl-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate

Also Published As

Publication number Publication date
RU2119480C1 (ru) 1998-09-27
CZ289096B6 (cs) 2001-11-14
NO940506L (cs) 1994-08-16
GR3034957T3 (en) 2001-02-28
FI940659A7 (fi) 1994-08-16
NO300810B1 (no) 1997-07-28
ATE196141T1 (de) 2000-09-15
PT611767E (pt) 2001-02-28
PL302213A1 (en) 1994-08-22
FI106716B (fi) 2001-03-30
PL177834B1 (pl) 2000-01-31
US5395840A (en) 1995-03-07
AU672262B2 (en) 1996-09-26
CZ32994A3 (en) 1994-08-17
IL108625A (en) 1997-09-30
ZA94984B (en) 1994-08-24
UA35574C2 (uk) 2001-04-16
MY131595A (en) 2007-08-30
AU5480794A (en) 1994-08-18
SK15294A3 (en) 1994-12-07
CA2115536A1 (en) 1994-08-16
PH30172A (en) 1997-01-21
EP0611767B1 (de) 2000-09-06
FI940659A0 (fi) 1994-02-11
EP0611767A1 (de) 1994-08-24
KR940019708A (ko) 1994-09-14
CN1108257A (zh) 1995-09-13
CN1057085C (zh) 2000-10-04
DE4304455A1 (de) 1994-08-18
DE59409509D1 (de) 2000-10-12
IL108625A0 (en) 1994-05-30
NZ250864A (en) 1995-03-28
CA2115536C (en) 2004-11-02
JPH06293741A (ja) 1994-10-21
ES2151908T3 (es) 2001-01-16
NO940506D0 (no) 1994-02-14

Similar Documents

Publication Publication Date Title
DK0611767T3 (da) Heterocyclisk substituerede phenylcyclohexancarboxylsyrederivater som angiotension II-antagonister
NO2004009I1 (no) Melagatran, stereoisomerer derav eller fysiologisksalter eller estrer derav
NO960949D0 (no) Tablettert flerdoseenhetsform inneholdende protonpumpeinhibitor
DK0380331T3 (da) Anvendelse af di-tert.butylhydroxyphenylthioderivater til fremstilling af et lægemiddel til behandling eller forebyggelse af arteriosklerose eller atherosklerose
DE59407431D1 (de) Verwendung aromatischer Carbonsäurederivate zur Herstellung von pharmazeutischen Präparaten
CS129190A3 (en) Herbicidally active ester of/|(1,3,5-triazin-2-yl)aminocarbonyl¨aminosulfonyl/benzoic acid, process of itspreparation and use
ATE308322T1 (de) Arzneimittel zur behandlung der herzinsuffizienz
AU2443888A (en) Agents for treating high blood pressure and cardiac insufficiency
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ES2117114T3 (es) Nuevos derivados de tiaxolidin-diona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE58907390D1 (de) Sulfonamide mit Tetrazolylrest, Verfahren zu ihrer Herstellung sowie Arzneimittel.
EP0950409A4 (en) INHIBITORS OF SUBEPITHELIAL TURBIDITY
DE59105323D1 (de) Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen.